SEMINARIO N4
3
SEMINARIO Nº 4 PSICOFÁRMACOS 1. Benzodiacepinas: farmacología, indicaciones, contraindicaciones y uso en status epiléptico. 2. Hipnóticos: farmacología, usos y reacciones adversas. 3. Antidepresivos de nueva generación: farmacología, indicaciones y contraindicaciones. 4. Intoxicación por psicofármacos: manejo y uso de antagonistas. Psicofármacos en el embarazo. BIBLIOGRAFÍA 1. Baumann P, Zullino DF, Eap CB. Enantiomers’ potential in psychopharmacology-a critical analysis with special emphasis on the antidepressant escitalopram. Eur Neuropsychopharmacol. 2002 Oct: 12(5):433-44. 2. Kilts CD. The changing roles and targets for animal models of schizophrenia. Biol Psychiatry. 2001 Dec 1;50(11):845-55. 3. Verhoeven WM, Tuinier S. Two steps forward, one step back; paradigmatic changes in psychiatry. J Neural Transm. 2001;108(6):617-27. 4. Sampson SM. Treating depression with selective serotonin reuptake inhibitors: a practical approach. Mayo Clin Proc. 2001 Jul;76(7):739-44. 5. Overall KL. Pharmacological treatment in behavioural medicine: the importance of neurochemistry, molecular biology and mechanistic hypotheses. Vet J. 2001 Jul;162(1):9-23. 6. Ban TA. Pharmacotherapy of mental illness-a historical analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2001 May;25(4):709-27. 7. Pickar D, Rubinow K. Pharmacogenomics of psychiatric disorders. Trends Pharmacol Sci. 2001 Feb;22(2):75-83. 8. Brunello N, Armitage R, Feinberg I, Holsboer-Trachsler E, Leger D, Linkowski P, Mendelson WB, Racagni G, Saletu B, Sharpley AL, Turek F, Van Cauter E, Mendlewicz J. Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment. Neuropsychobiology. 2000;42(3):107-19. 9. Cowen PJ. Psycopharmacology of 5-HT(1A) receptors. Nucl Med Biol. 2000 Jul;27(5):437-9. 10. Stephenson CM, Pilowsky LS. Psychopharmacology of olanzapine. A review. Br J Psychiatry Suppl. 1999;(38):52-8. 11. Gold LH. Treatment of depression during pregnancy. J Womens Health Gend Based Med. 1999 Jun;8(5):601-7. 12. Von Moltke LL, Greenblatt DJ. Drug transporters in psychopharmacology—are they important? J Clin Psychopharmacol. 2000 Jun;20(3):291-4. 13. Psychopharmacology. (Review) Thomas H. Lewis. JAMA, The Journal of the American Medical Association. April 21, 1999 v281 i15 p1438(1).
Transcript of SEMINARIO N4
SEMINARIO Nº 4PSICOFÁRMACOS
1. Benzodiacepinas: farmacología, indicaciones, contraindicaciones y uso en status epiléptico.2. Hipnóticos: farmacología, usos y reacciones adversas.3. Antidepresivos de nueva generación: farmacología, indicaciones y contraindicaciones.4. Intoxicación por psicofármacos: manejo y uso de antagonistas. Psicofármacos en el embarazo.
BIBLIOGRAFÍA1. Baumann P, Zullino DF, Eap CB. Enantiomers’ potential in psychopharmacology-a critical analysis
with special emphasis on the antidepressant escitalopram. Eur Neuropsychopharmacol. 2002 Oct: 12(5):433-44.
2. Kilts CD. The changing roles and targets for animal models of schizophrenia. Biol Psychiatry. 2001 Dec 1;50(11):845-55.
3. Verhoeven WM, Tuinier S. Two steps forward, one step back; paradigmatic changes in psychiatry. J Neural Transm. 2001;108(6):617-27.
4. Sampson SM. Treating depression with selective serotonin reuptake inhibitors: a practical approach. Mayo Clin Proc. 2001 Jul;76(7):739-44.
5. Overall KL. Pharmacological treatment in behavioural medicine: the importance of neurochemistry, molecular biology and mechanistic hypotheses. Vet J. 2001 Jul;162(1):9-23.
6. Ban TA. Pharmacotherapy of mental illness-a historical analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2001 May;25(4):709-27.
7. Pickar D, Rubinow K. Pharmacogenomics of psychiatric disorders. Trends Pharmacol Sci. 2001 Feb;22(2):75-83.
8. Brunello N, Armitage R, Feinberg I, Holsboer-Trachsler E, Leger D, Linkowski P, Mendelson WB, Racagni G, Saletu B, Sharpley AL, Turek F, Van Cauter E, Mendlewicz J. Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment. Neuropsychobiology. 2000;42(3):107-19.
9. Cowen PJ. Psycopharmacology of 5-HT(1A) receptors. Nucl Med Biol. 2000 Jul;27(5):437-9.10. Stephenson CM, Pilowsky LS. Psychopharmacology of olanzapine. A review. Br J Psychiatry Suppl.
1999;(38):52-8.11. Gold LH. Treatment of depression during pregnancy. J Womens Health Gend Based Med. 1999
Jun;8(5):601-7.12. Von Moltke LL, Greenblatt DJ. Drug transporters in psychopharmacology—are they important? J
Clin Psychopharmacol. 2000 Jun;20(3):291-4.13. Psychopharmacology. (Review) Thomas H. Lewis. JAMA, The Journal of the American Medical
Association. April 21, 1999 v281 i15 p1438(1).14. Essential psychopharmacology: neuroscientific basis and clinical applications. (Review) Ronald B.
Mack. Journal of Toxicology: Clinical Toxicology. April 1999 v37 i3 p427.15. Soares JC, Gershon S. The psychopharmacologic specificity of the lithium ion: origins and trajectory.
J Clin Psychiatry. 2000;61 Suppl 9:16-22.16. Wing YK. Recent advances in the management of depression and psychopharmacology. Hong Kong
Med J. 2000 Mar;6(1):85-92.17. Heckers S, Konradi C. Anatomic and molecular principles of psychopharmacology. A primer for
psychiatrists. Child Adolesc Psychiatr Clin N Am. 2000 Jan;9(1):1-22.
CUESTIONARIO (El Profesor completará el cuestionario, según lo desarrollado en el Seminario).
1. Mecanismo de Acción de las Benzodiacepinas.2. Mecanismo de Acción de Hipnóticos.3. Principales características de los nuevos antidepresivos.4. Efectos adversos de ……………………5. (Formulada por el profesor)
